To cite this paper use one of the standards below:
Dietary docosahexaenoic acid modulates cell proliferation and annexin A1 expression in TRAMP prostate cancer model
Lucas Martins
Universidade Estadual Paulista “Júlio de Mesquita Filho”
Now you could share with me your questions, observations and congratulations
Create a topicIntroduction: Prostate cancer (PCa) is one of the most frequent malignancies in men. Inflammation is a crucial process in PCa onset and progression. Annexin A1 (ANXA1) is a downstream-target protein of corticosteroid signaling, exhibiting anti-inflammatory and pro-resolving actions. However, the role of ANXA1 in PCa is yet unclear. Recently, significant attention has been given to dietary compounds capable of delaying tumor progression, such as docosahexaenoic acid (DHA), a polyunsaturated fatty acid that exhibits several anti-tumor effects linked to its anti-inflammatory and anti-proliferative properties. Objectives: We aimed to report the tissue expression of ANXA1 during the tumor progression and the potential effects of DHA consumption, as well as its implications for disease progression. Methods: Transgenic adenocarcinoma of the mouse prostate (TRAMP) (n=10/group) were divided into the following groups: animals fed with a standard diet and euthanized at 12 or 18 weeks of age (C12 and C18) or animals fed with a fish oil-enriched diet (DHA-d) and euthanized (D12 and D18) (CEUA: 5884-1/2021 - UNICAMP). The ventral prostate was collected for morphological and western blotting analyses, and blood samples were collected to determine the serum levels of TNF-α through immunoenzymatic assay. Results: Carcinoma in situ (CIS) was observed in C12, but was not found in D12. 40% of C18 presented undifferentiated adenocarcinoma (UDAC), while only half was observed in D18. For both D12 and D18 groups, a reduction in the levels of PHH3+ cells was observed. In the D12 group, this reduction was associated with a 3.6-fold increase in the protein levels of pERK1/2 and a reduction of 2.55-fold in the levels of pAKT in D18. A progressive increase in ANXA1 expression was observed in pre-malignant lesions in both C12 and C18 groups, with a gradual reduction in well-differentiated adenocarcinoma (WDAC) and UDAC in the C18 group. DHA-d increased ANXA1 expression in low-grade prostatic intraepithelial neoplasia (LGPIN), reduced it in high-grade prostatic intraepithelial neoplasia (HGPIN) and well-differentiated adenocarcinoma (WDAC). A reduction of ~65% in glucocorticoid receptor (GR) protein levels was observed in both DHA-d groups, as well as a decrease in TNF-α levels (2.3-fold for D12 and 1.4-fold for D18). Conclusions: Overall, our data suggest that the expression of ANXA1 increases in premalignant lesions of TRAMP mice prostate with the highest expression in HGPIN, and decreases in malignant lesions. The DHA-d t reduces the expression of GR in the gland and also the expression of ANXA1 in HGPINs and WDAC. In vivo data validates the action of DHA in delaying tumor progression in TRAMP mice, delineating new strategies that GR signaling and ANXA1 protein play in this important mechanism.
João Marcelo Porcionato
Can tell us about a possible preventive power of the DHA-d in prostate Cancer?
How can we use this information in public health?
João Marcelo Porcionato
Could you tell me if there are any contraindications for using DHA-d?
Lucas Martins
There aren't really any contraindications to the consumption of a DHA-d, nevertheless, it is important to notice that due to the fact that DHA is an omega-3 fatty acid, its consumption is linked to a higher caloric intake, so it is recommended that if a person intends to incorporate DHA in their diet, they should be engaged in a healthy lifestyle, including regular physical activities.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper
Lucas Martins
The DHA-enriched diet's possible preventive power has been observed in preclinical models only, modulating multiple pathways involved in tumor initiation and progression. It is important to emphasize, however, that there are currently no clinical trials involving DHA consumption, and given that it is a dietary compound, the ideal approach is to consider the DHA-d as an adjunct in prostate cancer treatment. We can use this information in public health as a multiprofessional approach to improve a prostate cancer patient's quality of life during the treatment of the disease, encouraging a change in their dietary habits.